146 related articles for article (PubMed ID: 21724930)
1. Rash from hepatitis C treatment.
Tang DM; Ward L
Cleve Clin J Med; 2011 Jul; 78(7):472-4. PubMed ID: 21724930
[No Abstract] [Full Text] [Related]
2. When good drugs turn weirdly bad.
Mandell BF
Cleve Clin J Med; 2011 Jul; 78(7):426. PubMed ID: 21724925
[No Abstract] [Full Text] [Related]
3. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
Quinn D; Kuchler E; Deming P; Arora S
Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
[No Abstract] [Full Text] [Related]
4. Erythema gyratum repens induced by pegylated interferon alfa for chronic hepatitis C.
Rongioletti F; Fausti V; Parodi A
Arch Dermatol; 2012 Oct; 148(10):1213-4. PubMed ID: 23069974
[No Abstract] [Full Text] [Related]
5. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
Hu CC; Chien RN
Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
[No Abstract] [Full Text] [Related]
6. Severe renal impairment during triple therapy with telaprevir.
Carrier P; Chambaraud T; Vong C; Guillaudeau A; Debette-Gratien M; Jacques J; Legros R; Sautereau D; Essig M; Loustaud-Ratti V
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):e69-71. PubMed ID: 24461554
[No Abstract] [Full Text] [Related]
7. [Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure].
Virolés Torrent S; López Nuñez C; Hombrados Verde M; Figa Francesch M; Ferri Iglesias MJ; Louvriex Freire R; Acero Fernández D
Gastroenterol Hepatol; 2015 Feb; 38(2):78-81. PubMed ID: 24948444
[No Abstract] [Full Text] [Related]
8. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
Castellanos González M; Pérez Carreras M; Muñoz Gómez R; Castellano Tortajada G
Gastroenterol Hepatol; 2011 Oct; 34(8):584-5. PubMed ID: 21641684
[No Abstract] [Full Text] [Related]
9. [Information for patients. Treatment of acute hepatitis C].
Otón Nieto E
Rev Esp Enferm Dig; 2011 Oct; 103(10):549. PubMed ID: 22054273
[No Abstract] [Full Text] [Related]
10. Erythema Annulare Centrifugum in the Era of Triple Therapy With Boceprevir Plus Pegylated Interferon α-2b and Ribavirin for Hepatitis C Virus Infection.
di Meo N; Stinco G; Fadel M; Errichetti E; Trevisan G
J Cutan Med Surg; 2015; 19(3):203-4. PubMed ID: 26060126
[No Abstract] [Full Text] [Related]
11. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
[No Abstract] [Full Text] [Related]
12. Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection.
Puoti C; Lanzetta G; Scotti E
J Gastrointestin Liver Dis; 2016 Sep; 25(3):408-9. PubMed ID: 27689211
[No Abstract] [Full Text] [Related]
13. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
Demirturk N; Aykin N; Demirdal T; Cevik F
Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
[No Abstract] [Full Text] [Related]
14. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
15. Tongue hyperpigmentation during hepatitis C treatment.
Bachmeyer C; Pellen JC
CMAJ; 2012 Sep; 184(13):1498. PubMed ID: 22451683
[No Abstract] [Full Text] [Related]
16. "Hepatitis C (HCV) treatment is not a "one size fits all".
Bukeirat FA; Bukeirat MM
W V Med J; 2012; 108(2):20, 22-4. PubMed ID: 22655431
[TBL] [Abstract][Full Text] [Related]
17. De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).
Fabrizi F; Aghemo A; Moroni G; Passerini P; D'Ambrosio R; Martin P; Messa P
Dig Dis Sci; 2014 Mar; 59(3):691-5. PubMed ID: 24318802
[No Abstract] [Full Text] [Related]
18. Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature.
Mlika RB; Kerkeni N; Marrak H; Fenniche S; Mokhtar I; Debbiche A
Int J Dermatol; 2013 May; 52(5):643-4. PubMed ID: 23046405
[No Abstract] [Full Text] [Related]
19. Hepatitis C treatment, HAART and side effects.
TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
[No Abstract] [Full Text] [Related]
20. Peginterferon and ribavirin for chronic hepatitis C.
Hoofnagle JH; Seeff LB
N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
